Cagrilintide (Appetite Control Peptide)

Cagrilintide is a long-acting synthetic amylin analogue developed for weight management. It works on amylin receptors involved in appetite regulation and satiety, helping people feel fuller for longer and potentially reducing overall calorie intake. It has been investigated both as a standalone treatment and in combination with Semaglutide and Retatrutide.

Potential Benefits

• Appetite Suppression: May help reduce hunger and food cravings.
• Increased Satiety: Promotes feelings of fullness after eating.
• Weight Management: Clinical trials have demonstrated potential for significant weight loss.
• Reduced Calorie Intake: May help reduce overall food consumption by influencing appetite.
• Combination Potential: Being investigated alongside semaglutide for enhanced weight-management effects.

Possible Side Effects

• Gastrointestinal Issues: Nausea, vomiting and diarrhoea are among the most common reported side effects.
• Digestive Discomfort: Constipation, abdominal discomfort and reduced appetite may occur.